Investor profile
Noubar Afeyan
Accelerator, Corporate VC, Venture capital & Founder at Flagship Pioneering, Co-Founder and Chairman at Moderna
Noubar Afeyan is a Founder at Flagship Pioneering, whose known portfolio counts 9 companies.
Is Noubar Afeyan a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Focus
- AgriTechBiotechDrug DiscoveryFoodTechGene EditingGeneticsGenomicsLife ScienceMachine LearningTherapeuticsVenture StudiomRNA therapeutics
Contacts
Affiliated funds' portfolios
Founder at Flagship Pioneering, whose known portfolio counts 9 companies
- Lila Sciences
- Harbinger Health
- Ampersand Biomedicines
- Etiome
- Expedition Medicines
- Extuitive
- Foghorn Therapeutics
- Serif Biomedicines
- Terrana Biosciences
Co-Founder and Chairman at Moderna, whose known portfolio counts 5 companies
- Metagenomi
- Immatics Biotechnologies
- Leightal Capital Management
- Generation Bio
- Onkaido Therapeutics
Investor Profile
Founders in the listed sectors AI, Climate, Food and Healthcare, and focus areas AgriTech, Biotech, Drug Discovery and FoodTech fall inside that listing.
Flagship Pioneering appears in Late-Stage, Seed and Series A rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Noubar Afeyan is worth approaching.
Colleagues
Showing 20 of 47
Margo Georgiadis
CEO/Partner
San Francisco, United States
Hok Hei Tam
Science Partner
Cambridge, United States
Avak Kahvejian
General Partner
Cambridge, United States
Ignacio Martinez
General Partner
Boston, United States
Ajit Singh
CEOPartner
Palo Alto, United States
Jason Park
Partner
Cambridge, United States
Geoffrey von Maltzahn
General Partner
Cambridge, United States
Bernard Cooney
Senior Partner
Cambridge, United States
Jacob Rubens
Origination Partner
Cambridge, United States
Stephen Berenson
Advisor Partner
United States
Torben Straight Nissen
Executive Partner
Boston, United States
Guillaume Pfefer
CEO Partner Senda Biosciences
Boston, United States
Marie Yurkovich
Biotech Company Creation
New York City, United States
Sophie de Boer
Senior Principal
Cambridge, United States
Alex Goldsmith
Vice President, Global Scientific Engagement
Cambridge, United States
Nathan Stebbins
Senior Principal
Los Angeles, United States
Ewen Cameron
Operating Partner
Boston, United States
Olivia Arnold
Venture Creation Associate
Boston, United States
Murillo Silva
Senior Associate in Venture Creation
Boston, United States
Young Guang
Investor
Boston, United States
Frequently asked questions
Who is Noubar Afeyan?
Noubar Afeyan is an accelerator partner and corporate venture investor based in Cambridge, Massachusetts, United States, listed as Founder at Flagship Pioneering. The known portfolio of that firm counts 9 companies. That portfolio belongs to the firm, not to Noubar Afeyan personally.
What does Noubar Afeyan invest in?
Listed sectors include AI, Climate, Food and Healthcare; listed focus areas include AgriTech, Biotech, Drug Discovery and FoodTech. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Noubar Afeyan invest at?
Flagship Pioneering appears in Late-Stage, Seed and Series A rounds across its known deals, and Noubar Afeyan is listed there as Founder. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Noubar Afeyan listed at?
Noubar Afeyan is listed as Founder at Flagship Pioneering. 47 other people in the database share a firm with Noubar Afeyan.
How do I contact Noubar Afeyan?
An email address and a LinkedIn page are on file for Noubar Afeyan. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal